IMMUNIC, INC.
Pharmaceutical Preparations · NEW YORK
Moderate confidence (50%)
Updated Oct 9, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: IMMUNIC, INC. received a delisting notice from its exchange (Jan 5, 2026)
Timeline
Every material event, newest first. History is never overwritten.
IMMUNIC, INC. received a delisting notice from its exchange
Jan 5, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 5, 2026, Immunic, Inc. (the Company ) received approval (the Approval ) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) that the Company s application to transfer the listing of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market has been approved. The common stock will be transferred to the Nasdaq Capital Market at the opening of business on January 7, 2026. The common stock will continue to trade…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker IMUX on Nasdaq.
- SEC CIK
- 0001280776
- Website
- —
- —
- Headquarters
- NEW YORK
- Also known as
- VITAL THERAPIES INC
- Legal entities
- IMMUNIC, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
IMMUNIC, INC. — Pharmaceutical Preparations (SIC 2834) — NEW YORK, United States
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 5, 2026, Immunic, Inc. (the Company ) received approval (the Approval ) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) that the Company s application to transfer the listing of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market has been approved. The common stock will be transferred to the Nasdaq Capital Market at the opening of business on January 7, 2026. The common stock will continue to trade…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:32 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.